Related Experiment Videos
Rituximab: active treatment of central nervous system involvement by non-Hodgkin's lymphoma?
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Fear, Pain, Denial, and Spiritual Experiences in Dying Processes.
The American journal of hospice & palliative care·2017
The Range of Neurological Complications in Chikungunya Fever.
Neurocritical care·2017
Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysis.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2014
Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study.
European journal of clinical pharmacology·2014
Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic radiation is associated with worse outcomes in patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026